Characterizing resource use and treatment costs for chronic myelogenous leukemia (CML) in the united states (US)

被引：0
|
作者：
Levy, A. R.
Bavinton, H.
Davis, C.
机构：
[1] Oxford Outcomes Ltd, Vancouver, BC, Canada
[2] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)68935-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A130 / A130
页数：1
相关论文
共 50 条
  • [1] CHARACTERIZING RESOURCE USE AND TREATMENT COSTS FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE UK (UK)
    Szabo, S. M.
    Davis, C.
    Sidhu, S.
    Levy, A. R.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A268 - A268
  • [2] RESOURCE USE AND COSTS ASSOCIATED WITH THE TREATMENT OF ADVERSE EVENTS IN CHRONIC MYELOID LEUKEMIA (CML) BRAZILIAN PATIENTS
    Alves, M. R.
    Boquimpani, C.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A91 - A91
  • [3] United States (US) practices for chronic myelogenous leukemia (CML) management compared to other countries: A worldwide observational registry.
    Hermann, R. C.
    Miller, C. B.
    Catchatourian, R.
    Snyder, D.
    Williams, D.
    Juma, M.
    Cortes, J. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Development of a curative treatment program for chronic myelogenous leukemia (CML).
    Clarkson, B
    Veach, D
    Bornmann, WG
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U434 - U434
  • [5] Chronic Myelogenous Leukemia (CML) in the elderly
    Balducci, Lodovico
    Dolan, Dawn
    [J]. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2014, 6 (01):
  • [6] Costs of drugs in oncology. The cases of chronic myelogenous leukemia (CML) and immunotherapy
    Hochhaus, A.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 114 - 114
  • [7] Understanding United States (US) Treatment Practices for the Management of Chronic Myeloid Leukemia (CML) in Clinical Practice: A US Subgroup Analysis of the WORLD CML Registry.
    Hermann, Robert
    Miller, Carole B.
    Catchatorian, Rosalind
    Snyder, David S.
    Ericson, Solveig G.
    Zernovak, Oleg
    Juma, Matthews A.
    Cortes, Jorge E.
    [J]. BLOOD, 2012, 120 (21)
  • [8] Substance Use and Survival after Treatment for Chronic Myelogenous Leukemia (CML) or Myelodysplastic Syndrome (MDS)
    Chang, Grace
    Meadows, Mary-Ellen
    Jones, Jennifer A.
    Antin, Joseph H.
    Orav, E. John
    [J]. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2010, 36 (01): : 1 - 6
  • [9] The Symptom Burden of Chronic Myelogenous Leukemia (CML)
    Williams, Loretta A.
    Ault, Patricia
    Wang, Xin Shelley
    Cleeland, Charles S.
    Mendoza, Tito R.
    Mobley, Gary M.
    Cortes, Jorge E.
    [J]. BLOOD, 2008, 112 (11) : 839 - 840
  • [10] BONE INVOLVEMENT IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
    TRIPATHY, K
    GOMEZ, GA
    PARK, J
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 153 - 153
12345